secwatch.observer — SEC 8-K summary
======================================

Issuer:     LENZ Therapeutics, Inc. (LENZ)
CIK:        0001815776
Form:       8-K
Filed at:   2025-06-10T23:59:59+00:00
Accession:  0001815776-25-000036
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

LENZ Therapeutics annual meeting elects directors, ratifies auditor
-------------------------------------------------------------------

- 17,983,676 of 27,544,520 shares represented at June 10, 2025 annual meeting.
- Class III directors Kimberlee C. Drapkin and Zach Scheiner elected with ~12.4M and ~12.7M votes for.
- Class I directors Frederic Guerard and James McCollum elected with ~15.4M and ~15.4M votes for.
- Ernst & Young LLP ratified as independent auditor for FY2025 with 17,979,770 votes for.
- No proposals or business items beyond standard director elections and auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815776/000181577625000036/0001815776-25-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815776/000181577625000036/lenz-20250610.htm
  HTML page:      https://secwatch.observer/filing/0001815776-25-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer